Pharmacists' preferences for the provision of services to improve medication adherence among patients with diabetes in Indonesia: Results of a discrete choice experiment.
adherence
diabetes
discrete choice experiment
pharmacist
preference
services
Journal
Health & social care in the community
ISSN: 1365-2524
Titre abrégé: Health Soc Care Community
Pays: England
ID NLM: 9306359
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
revised:
22
03
2021
received:
03
09
2020
accepted:
22
04
2021
pubmed:
20
5
2021
medline:
31
12
2021
entrez:
19
5
2021
Statut:
ppublish
Résumé
Little is known about pharmacists' preferences for services to improve medication adherence in patients with diabetes in Indonesia. Identification of such preferences can provide valuable insights on suitable services from a pharmacist's perspective. This study elicits pharmacists' preferences for services to improve medication adherence among their patients. A discrete choice experiment (DCE) method was used to survey pharmacists in all community health centres and three hospitals in Surabaya, Indonesia. Four attributes of consultation, namely duration of consultation, place of consultation, access to a pharmacist and patient copayment, and two attributes on additional services (educational and behavioural-based services) were included. The 16 profiles generated for DCE were partially balanced and partially without overlap. A random-effect logistic regression was used in the analysis. In total, 99 pharmacists completed the questionnaire, but only 80 were included in the study based on a consistency check. All attributes were found to determine preferences for a pharmacist service package. Pharmacists preferred a consultation with a shorter duration accompanied by flexible access to the pharmacist as well as a private consultation room and a lower patient copayment. Providing the patient with a brochure/leaflet was the most preferred additional service to help improve medication adherence. Patient group discussion and medication review were also preferred in combination with a consultation. Pharmacists' socio-demographic background characteristics influence preferences. These findings can be considered in evaluating current practice and designing pharmacist services to help improve medication adherence among patients with diabetes.
Identifiants
pubmed: 34009714
doi: 10.1111/hsc.13423
pmc: PMC9292582
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e161-e174Informations de copyright
© 2021 The Authors. Health and Social Care in the Community published by John Wiley & Sons Ltd.
Références
Pharmacoeconomics. 2012 Oct 1;30(10):961-76
pubmed: 22823521
Diabet Med. 2020 Nov;37(11):1807-1815
pubmed: 31001855
Diabetes Care. 2019 Jan;42(Suppl 1):S1-S2
pubmed: 30559224
J Clin Pharm Ther. 2017 Dec;42(6):738-749
pubmed: 28627110
BMJ Open. 2013 Sep 11;3(9):e003214
pubmed: 24030867
Res Social Adm Pharm. 2013 Nov-Dec;9(6):777-89
pubmed: 23127392
Pharmacoeconomics. 2007;25(9):783-92
pubmed: 17803336
Diabetes Care. 2005 Apr;28(4):771-6
pubmed: 15793171
Value Health. 2016 Jun;19(4):300-15
pubmed: 27325321
J Young Pharm. 2013 Jun;5(2):38-40
pubmed: 24023452
Health Policy Plan. 2009 Mar;24(2):151-8
pubmed: 19112071
Br J Gen Pract. 2019 Mar;69(680):e190-e198
pubmed: 30745357
Diabet Med. 2015 Jun;32(6):725-37
pubmed: 25440507
Res Social Adm Pharm. 2011 Dec;7(4):396-405
pubmed: 21272537
Value Health. 2011 Jun;14(4):403-13
pubmed: 21669364
Integr Pharm Res Pract. 2017 Jan 16;6:15-27
pubmed: 29354547
Value Health. 2013 Jan-Feb;16(1):3-13
pubmed: 23337210
Saudi Pharm J. 2016 Jul;24(4):441-6
pubmed: 27330374
Pharm World Sci. 2007 Apr;29(2):81-9
pubmed: 17136586
Health Expect. 2016 Oct;19(5):1098-110
pubmed: 26332335
Ann Pharmacother. 2017 Dec;51(12):1069-1076
pubmed: 28737045
Res Social Adm Pharm. 2019 Jun;15(6):641-649
pubmed: 30143466
Diabetes Care. 2004 May;27(5):1218-24
pubmed: 15111553
Diabetes Ther. 2016 Dec;7(4):755-764
pubmed: 27718218
Res Social Adm Pharm. 2019 Sep;15(9):1057-1067
pubmed: 30685443
Integr Pharm Res Pract. 2017 Jan 25;6:37-46
pubmed: 29354549
J Pharm Pract. 2013 Apr;26(2):120-4
pubmed: 22797831
Ann Pharmacother. 2010 Oct;44(10):1554-64
pubmed: 20841513
J Cardiovasc Pharmacol Ther. 2012 Mar;17(1):57-64
pubmed: 21335480
Health Soc Care Community. 2022 Jan;30(1):e161-e174
pubmed: 34009714
Pharm World Sci. 2008 Aug;30(4):360-6
pubmed: 18193337